×
0 0 0.00196463654223982 -0.00540275049115911 -0.00540275049115911 -0.0147347740667977 0.00196463654223982 -0.0697445972495088
Stockreport

CytomX's stock rockets after expanding Bristol-Myers collaboration [MarketWatch]

CYTOMX THERAPEUTICS (CTMX)  More Company Research Source: MarketWatch
Last cytomx therapeutics earnings: 11/7 04:57 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com
PDF CytomX's stock rockets after expanding Bristol-Myers collaboration CytomX Therapeutics Inc.'s stock CTMX, +1.20% rocketed 25% toward a 14-month high in premarket trade Monday, after the company said it would receive a $200 million upfront payment from Bristol-Myers Squibb Co. BMY, -1.78% as part of the expansion of a collaboration pact to discover cancer treatments using CytomX's Probody platform. CytomX will also be eligible to receive up to $448 million in milestone payments, as well as royalty payments, if development, regulatory and sales targets are met. "CytomX's Probody platform has enhanced our discovery research as we seek to direct the therapeutic effects of immunotherapy in a more targeted approach against tumors," said Bristol-Myers Head of Discovery Carl Decicco. CytomX's stock had climbed 32% over the past three months through Friday, while Bristol-Myers shares had lost 4.8% and the S&P 500 SPX, -0.13% had gained 4.7%. [Read more]

IMPACT SNAPSHOT EVENT TIME: CTMX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS